Table 1. Facility characteristics and vaccine knowledge, practices, and management for the countries with Hepatitis B birth dose assessments1.
| STP (n=5) | Nigeria (n=23) | Gambia (n=9) | Botswana (n=16) | |
|---|---|---|---|---|
| Background characteristics | ||||
| Total number of deliveries (median [range]) | 336 (31–4,383) | 278 (25–1,667) | 1719 (500–6,000) | 167 (19–6,000) |
| 100% of mothers stay >=24h post delivery | 5 (100%) | 10 (43%) | 3 (33%) | 2 (13%) |
| Staff Knowledge | ||||
| Received training on HepB-BD | 4 (80%) | 14 (61%) | 6 (56%) | 2 (13%) |
| Know that a mother can transmit HBV to her baby | 5 (100%) | 23 (100%) | 8 (92%) | 12 (75%) |
| Know that recommended HepB-BD administration is <24h of birth | 5 (100%) | 23 (100%) | 7 (71%) | 14 (88%) |
| Practices | ||||
| Vaccinate ALL newborns with HepB-BD | 0 (0%) | 23 (100%) | 9 (100%) | 16 (100%) |
| Follow standard written protocols for HepB-BD administration | 0 (0%) | 6 (26%) | 0 (100%) | 0 (100%) |
| Provide written documentation of HepB-BD to mother | 5 (100%) | 22 (96%) | 9 (100%) | 16 (100%) |
| Vaccinate in the delivery room | 5 (100%) | 6 (26%) | 0 (100%) | 1 (6%) |
| Administer to very low weight babies (<2kg) | 4 (80%) | 9 (39%) | 2 (22%) | 0 (0%) |
| Administer to premature babies | 3 (60%) | 6 (26%) | 1 (11%) | 1 (6%) |
| Administer to ill but stable babies | 1 (20%) | 7 (30%) | 2 (22%) | 1 (6%) |
| Provide HepB-BD outreach vaccination to home births | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Charge patient for HepB-BD administration | 0 (0%) | 2 (9%) | 0 (0%) | 2 (13%) |
| Patients sometimes refuse HepB-BD | 0 (0%) | 1 (4%) | 0 (0%) | 1 (6%) |
| Offer HepB-BD vaccination daily | 5 (100%) | 0 (0%) | 0 (0%) | 16 (100%) |
| Require a physician order for HepB-BD | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Vaccine management | ||||
| Stock out >2 weeks in 2014 | 0 (0%) | 0 (0%) | 0 (0%) | 2 (13%) |
| Vaccine fridge is EPI-approved | 5 (100%) | 12 (52%) | 9 (100%) | 16 (100%) |
| Observed VVM stage 3-4 in fridge | 0 (0%) | 1 (4%) | 0 (0%) | 0 (0%) |
| Fridge monitored at least 2x/day | 5 (100%) | 6 (26%) | 9 (100%) | 16 (100%) |
| Vaccine obtained from MOH EPI | 5 (100%) | 23 (100%) | 9 (100%) | 16 (100%) |
| Implement multi-dose vial policy | 23 (100%) | 9 (100%) | 16 (100%) | |
1
A modified protocol was employed in Namibia as the HepB-BD assessment was embedded in a larger comprehensive EPI and surveillance review, and did not include comprehensive facility assessment component.